Sanofi
Search results
Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products. Section Overview
Boehringer Ingelheim is a global group of companies whose aim is to improve the lives of both humans and animals. Click here to find out more about us.
C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one.
Boehringer Ingelheim. We have been transforming lives in healthcare since 1885. Our 53,500 employees in 130 markets create value through innovation by infusing long-term, sustainable thinking into our Human Pharma and Animal Health units.
Boehringer Ingelheim | 1,805,414 followers on LinkedIn. Our people are our strength. And, together with over 56,000 colleagues, we're creating the next breakthrough in the world of health...
Schizophrenia is complex and stigmatized, demanding comprehensive understanding and care. Boehringer Ingelheim's commitment could revolutionize treatment, improving mental health and transforming lives. Visit story →
Key figure calculator. Download the Financial Report. About Cookies. In order to analyse the use and to improve our websites and to inform you about our company on other websites, we would like to use cookies. If you agree, please click “Accept all cookies”.
Boehringer Ingelheim | Annual Report 2022. Innovation drives us at Boehringer Ingelheim as we strive to positively impact lives of humans and animals with our innovative solutions. In 2022 we were able to help more people than ever before.
Apr 16, 2024 · Boehringer Ingelheim As one of the industry’s top investors in Research and Development, the company focuses on developing innovative therapies in areas of high unmet medical need.
Boehringer Ingelheim is a global, research-driven pharmaceutical company embracing many cultures and diverse societies. THERAPEUTIC AREA. Metabolic. About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 percent of all cases1.
